BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20819414)

  • 1. Impaired mitochondrial oxidative phosphorylation in multiple insulin-sensitive tissues of humans with type 2 diabetes mellitus.
    Wang M; Wang XC; Zhang ZY; Mou B; Hu RM
    J Int Med Res; 2010; 38(3):769-81. PubMed ID: 20819414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome.
    Skov V; Glintborg D; Knudsen S; Jensen T; Kruse TA; Tan Q; Brusgaard K; Beck-Nielsen H; Højlund K
    Diabetes; 2007 Sep; 56(9):2349-55. PubMed ID: 17563058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A PGC-1α- and muscle fibre type-related decrease in markers of mitochondrial oxidative metabolism in skeletal muscle of humans with inherited insulin resistance.
    Kristensen JM; Skov V; Petersson SJ; Ørtenblad N; Wojtaszewski JF; Beck-Nielsen H; Højlund K
    Diabetologia; 2014 May; 57(5):1006-15. PubMed ID: 24510228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus.
    Mensink M; Hesselink MK; Russell AP; Schaart G; Sels JP; Schrauwen P
    Int J Obes (Lond); 2007 Aug; 31(8):1302-10. PubMed ID: 17310221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligonucleotide microarray analysis reveals dysregulation of energy-related metabolism in insulin-sensitive tissues of type 2 diabetes patients.
    Wang M; Wang XC; Zhao L; Zhang Y; Yao LL; Lin Y; Peng YD; Hu RM
    Genet Mol Res; 2014 Jun; 13(2):4494-504. PubMed ID: 25036354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-specific control of mitochondrial respiration in obesity-related insulin resistance and diabetes.
    Holmström MH; Iglesias-Gutierrez E; Zierath JR; Garcia-Roves PM
    Am J Physiol Endocrinol Metab; 2012 Mar; 302(6):E731-9. PubMed ID: 22252943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-resistant muscle is exercise resistant: evidence for reduced response of nuclear-encoded mitochondrial genes to exercise.
    De Filippis E; Alvarez G; Berria R; Cusi K; Everman S; Meyer C; Mandarino LJ
    Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E607-14. PubMed ID: 18182465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weight-dependent manner.
    Brøns C; Jacobsen S; Nilsson E; Rönn T; Jensen CB; Storgaard H; Poulsen P; Groop L; Ling C; Astrup A; Vaag A
    J Clin Endocrinol Metab; 2010 Jun; 95(6):3048-56. PubMed ID: 20410232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGC-1alpha gene expression is down-regulated by Akt- mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle.
    Southgate RJ; Bruce CR; Carey AL; Steinberg GR; Walder K; Monks R; Watt MJ; Hawley JA; Birnbaum MJ; Febbraio MA
    FASEB J; 2005 Dec; 19(14):2072-4. PubMed ID: 16203862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes.
    Ducluzeau PH; Perretti N; Laville M; Andreelli F; Vega N; Riou JP; Vidal H
    Diabetes; 2001 May; 50(5):1134-42. PubMed ID: 11334418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiling following local muscle inactivity in humans provides new perspective on diabetes-related genes.
    Timmons JA; Norrbom J; Schéele C; Thonberg H; Wahlestedt C; Tesch P
    Genomics; 2006 Jan; 87(1):165-72. PubMed ID: 16326070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes.
    Misu H; Takamura T; Matsuzawa N; Shimizu A; Ota T; Sakurai M; Ando H; Arai K; Yamashita T; Honda M; Yamashita T; Kaneko S
    Diabetologia; 2007 Feb; 50(2):268-77. PubMed ID: 17187250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energy restriction prevents the development of type 2 diabetes in Zucker diabetic fatty rats: coordinated patterns of gene expression for energy metabolism in insulin-sensitive tissues and pancreatic islets determined by oligonucleotide microarray analysis.
    Colombo M; Kruhoeffer M; Gregersen S; Agger A; Jeppesen P; Oerntoft T; Hermansen K
    Metabolism; 2006 Jan; 55(1):43-52. PubMed ID: 16324918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine-improved visceral white adipose tissue insulin resistance associated with altered sterol regulatory element-binding proteins, liver x receptors, and peroxisome proliferator-activated receptors transcriptional programs in diabetic hamsters.
    Li GS; Liu XH; Zhu H; Huang L; Liu YL; Ma CM; Qin C
    Biol Pharm Bull; 2011; 34(5):644-54. PubMed ID: 21532151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans.
    Dray C; Debard C; Jager J; Disse E; Daviaud D; Martin P; Attané C; Wanecq E; Guigné C; Bost F; Tanti JF; Laville M; Vidal H; Valet P; Castan-Laurell I
    Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1161-9. PubMed ID: 20233941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.
    Amorim PA; Nguyen TD; Shingu Y; Schwarzer M; Mohr FW; Schrepper A; Doenst T
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1160-7. PubMed ID: 20850803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter.
    Sookoian S; Rosselli MS; Gemma C; Burgueño AL; Fernández Gianotti T; Castaño GO; Pirola CJ
    Hepatology; 2010 Dec; 52(6):1992-2000. PubMed ID: 20890895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion.
    Ling C; Del Guerra S; Lupi R; Rönn T; Granhall C; Luthman H; Masiello P; Marchetti P; Groop L; Del Prato S
    Diabetologia; 2008 Apr; 51(4):615-22. PubMed ID: 18270681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes.
    Frederiksen CM; Højlund K; Hansen L; Oakeley EJ; Hemmings B; Abdallah BM; Brusgaard K; Beck-Nielsen H; Gaster M
    Diabetologia; 2008 Nov; 51(11):2068-77. PubMed ID: 18719883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant gene expression in skeletal muscle and adipose tissue of patients with type 2 diabetes: effect of interleukin-6 infusion.
    Carey AL; Petersen EW; Bruce CR; Southgate RJ; Pilegaard H; Hawley JA; Pedersen BK; Febbraio MA
    Diabetologia; 2006 May; 49(5):1000-7. PubMed ID: 16538490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.